SQZ Biotechnologies Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- SQZ Biotechnologies's estimated annual revenue is currently $17.2M per year.
- SQZ Biotechnologies received $72.0M in venture funding in August 2018.
- SQZ Biotechnologies's estimated revenue per employee is $155,000
- SQZ Biotechnologies's total funding is $102.1M.
- SQZ Biotechnologies has 111 Employees.
- SQZ Biotechnologies grew their employee count by 3% last year.
- SQZ Biotechnologies currently has 8 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Cell Signaling ...||$89.4M||577||N/A||N/A|
What Is SQZ Biotechnologies?
SQZ Biotech is a unique cell therapy company, utilizing the proprietary CellSqueeze® platform to develop a new generation of cell therapies. SQZ currently focuses on the development of novel treatments that leverage targeted immune modulation to impact oncology and autoimmune diseases. SQZ: Empower cells to change lives.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
|Larry Knopf||General Counsel|
|Ashley Jones||Sr. Director Of Culture & People|
|Defne Yarar||Director, Cancer Immunology|
|Samantha DeTore||Senior People Partner|
|Tarek Abdeljawad||Senior Director, Process Development & Manufacturing|
|Ildefonso Vicente-Suarez||Principal Investigator|
|Volker Herrmann||Chief Operating Officer And President|
|Jason Murray||Manager, Process Development|
|David Chirgwin||Associate Director - Process Development And Manufacturing|
SQZ Biotechnologies News
Teri Loxam is leaving her role as head of IR at Merck to become the chief financial officer at SQZ Biotechnologies, a private firm focused on ...
Erytech Pharma has inked a deal with SQZ Biotechnologies Inc. to ... Erytech will licence the rights to use its ERYCAPS platform to SQZ, which ...
SQZ Biotech Announces Appointment of Experienced Pharmaceutical Executive Teri Loxam as Chief Financial Officer ...
SQZ Biotechnologies Funding
|2016-12-05||$4.0M||B||Quark Venture Inc||Article|
|2017-12-06||$Undisclosed||Undisclosed||JDRF T1D Fund.||Article|
SQZ Biotechnologies Executive Hires
|2016-10-03||Kris Elverum||Chief Business Officer||Article|
|2017-08-24||Shefali Agarwal||Chief Medical Officer||Article|
|2018-10-08||Volker Herrmann||chief operating officer and president||Article|
|2019-01-18||Oliver Rosen||Chief Medical Officer||Article|